Brigita Budginas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Brigita Budginas has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Alexander Tam
Department of Research, Noorda College of Osteopathic Medicine, 2162 S 180 E, Provo, UT 84606, USA
1 shared publication - Amanda McKenna
Department of Research, Noorda College of Osteopathic Medicine, 2162 S 180 E, Provo, UT 84606, USA
1 shared publication - Christina Small
Department of Research, Noorda College of Osteopathic Medicine, 2162 S 180 E, Provo, UT 84606, USA
1 shared publication - David L. Skaggs
Department of Orthopaedic Surgery, Cedars Sinai Medical Center, Los Angeles, California
1 shared publication - David Sant
Department of Research, Noorda College of Osteopathic Medicine, 2162 S 180 E, Provo, UT 84606, USA
1 shared publication - Hannah Hunsaker
Department of Research, Noorda College of Osteopathic Medicine, 2162 S 180 E, Provo, UT 84606, USA
1 shared publication
Latest Publications
- Open Access
Glucose Dysregulation as a Driver of Autoimmune Mimicry, Inflammation, and Psychiatric Symptoms: A Narrative Review
Background: Glycemic control influences a wide range of psychiatric and physiological symptoms. Many psychiatric conditions are linked to poor glucose regulation. Anti-nuclear antibodies (ANAs), widely used to screen for autoimmune disease, may sometimes reflect transient metabolic immune activation rather than chronic pathology. Evidence suggests that glucose dysregulation, including glycemic variability, reactive hypoglycemia, and postprandial spikes, can trigger systemic inflammation, neuropsychiatric symptoms, and temporary autoantibody production. This review explores how these metabolic phenomena complicate diagnosis and may contribute to misclassification or overtreatment. Methods: We conducted a narrative literature review prioritizing studies on immune activation, psychiatric outcomes, metabolic measures (including continuous glucose monitoring), and therapeutic interventions. Articles from the last ten years were emphasized, with older foundational studies included when relevant. Results: Metabolic instability drives immune dysregulation through macrophage polarization, mitochondrial dysfunction, oxidative stress, and impaired clearance of apoptotic debris. Glycemic variability correlates with increased inflammatory cytokines, autonomic dysfunction, and psychiatric symptoms such as anxiety, depression, and cognitive impairment. Emerging evidence from small studies suggests that correcting glucose abnormalities may reduce metabolic dysfunction and improve neuropsychiatric symptoms. Conclusions: Recognizing glucose dysregulation as a contributor to autoimmune-like and psychiatric symptoms may refine diagnostic and therapeutic approaches. Incorporating a dynamic holistic approach, which in practice includes metabolic assessments, dietary interventions, use of continuous glucose monitoring, and history of blood sugar instability, into rheumatologic and psychiatric evaluations could improve diagnostic precision, reduce unnecessary immunosuppression, and enhance patient outcomes.
Open AccessGlucose Dysregulation as a Driver of Autoimmune Mimicry, Inflammation, and Psychiatric Symptoms: A Narrative Review
Background: Glycemic control influences a wide range of psychiatric and physiological symptoms. Many psychiatric conditions are linked to poor glucose regulation. Anti-nuclear antibodies (ANAs), widely used to screen for autoimmune disease, may sometimes reflect transient metabolic immune activation rather than chronic pathology. Evidence suggests that glucose dysregulation, including glycemic variability, reactive hypoglycemia, and postprandial spikes, can trigger systemic inflammation, neuropsychiatric symptoms, and temporary autoantibody production. This review explores how these metabolic phenomena complicate diagnosis and may contribute to misclassification or overtreatment. Methods: We conducted a narrative literature review prioritizing studies on immune activation, psychiatric outcomes, metabolic measures (including continuous glucose monitoring), and therapeutic interventions. Articles from the last ten years were emphasized, with older foundational studies included when relevant. Results: Metabolic instability drives immune dysregulation through macrophage polarization, mitochondrial dysfunction, oxidative stress, and impaired clearance of apoptotic debris. Glycemic variability correlates with increased inflammatory cytokines, autonomic dysfunction, and psychiatric symptoms such as anxiety, depression, and cognitive impairment. Emerging evidence from small studies suggests that correcting glucose abnormalities may reduce metabolic dysfunction and improve neuropsychiatric symptoms. Conclusions: Recognizing glucose dysregulation as a contributor to autoimmune-like and psychiatric symptoms may refine diagnostic and therapeutic approaches. Incorporating a dynamic holistic approach, which in practice includes metabolic assessments, dietary interventions, use of continuous glucose monitoring, and history of blood sugar instability, into rheumatologic and psychiatric evaluations could improve diagnostic precision, reduce unnecessary immunosuppression, and enhance patient outcomes.
- 1 April 2026
- Published by Wolters Kluwer Health in JBJS Case Connector
- Vol. 16 (2)
Asymptomatic L5 Spondylolysis Does Not Necessarily Preclude Elite Gymnastics Participation
Case: An 8-year-old girl world-level rhythmic gymnast was diagnosed with bilateral L5 pars interarticularis defects and was asymptomatic. Imaging showed bilateral spondylolysis without spondylolisthesis or degeneration. Despite recommendations for sport restriction and external scrutiny, she continued elite training under specialist surveillance. Serial imaging over 18 years demonstrated persistent defects without progression. She competed internationally for >10 years without pain or limitation. Conclusion: Bilateral pediatric spondylolysis may remain clinically and radiographically stable despite extreme loading. This case highlights the importance of symptom-guided management and the psychosocial consequences of restrictive recommendations when radiographic findings do not correlate with clinical outcomes.
- 1 April 2026
- Published by Wolters Kluwer Health in JBJS Case Connector
- Vol. 16 (2)
Asymptomatic L5 Spondylolysis Does Not Necessarily Preclude Elite Gymnastics Participation
Case: An 8-year-old girl world-level rhythmic gymnast was diagnosed with bilateral L5 pars interarticularis defects and was asymptomatic. Imaging showed bilateral spondylolysis without spondylolisthesis or degeneration. Despite recommendations for sport restriction and external scrutiny, she continued elite training under specialist surveillance. Serial imaging over 18 years demonstrated persistent defects without progression. She competed internationally for >10 years without pain or limitation. Conclusion: Bilateral pediatric spondylolysis may remain clinically and radiographically stable despite extreme loading. This case highlights the importance of symptom-guided management and the psychosocial consequences of restrictive recommendations when radiographic findings do not correlate with clinical outcomes.